Skip to main content
Canadian Journal of Gastroenterology logoLink to Canadian Journal of Gastroenterology
. 2007 Jul;21(7):439–442. doi: 10.1155/2007/289059

Serological evidence of hepatitis E virus infection in an indigenous North American population

GY Minuk 1,2,, A Sun 1, DF Sun 1, J Uhanova 1, LE Nicolle 1, B Larke 3, A Giulivi 4
PMCID: PMC2657964  PMID: 17637946

Abstract

BACKGROUND:

Hepatitis E virus (HEV) infections are thought to be uncommon in North America. Recently, HEV transmission has been reported following the consumption of deer meat. Because deer are closely related to caribou and caribou meat is a staple of the Canadian Inuit and the American Eskimo diet, the present study explored the seroprevalence of HEV infection in an isolated Canadian Inuit community.

METHODS:

Stored sera were thawed and tested for immunoglobulin (Ig) G and IgM anti-HEV by ELISA, and tested for HEV-RNA by reverse transcriptase polymerase chain reaction.

RESULTS:

The study consisted of 393 sera (representing approximately 50% of the community’s inhabitants). Eleven samples (3%) were IgG anti-HEV-positive. Their mean age was 29±8 years and three were male. Two of 11 (18%) were also IgM anti-HEV-positive. All IgG anti-HEV-positive individuals were HEV-RNA-negative. Liver biochemistry was normal in all. Seven of 11 (64%) were also positive for anti-hepatitis A virus, five (46%) were hepatitis B virus seropositive and none (0%) were positive for anti-hepatitis C virus. There were no associations between infections with HEV and other hepatropic viruses. Serological testing was negative for HEV infection in 25 caribou from an adjacent region.

CONCLUSION:

The results of the present study showed that serological evidence of HEV infection was present in 3% of the observed Canadian Inuit population; the presence of IgM anti-HEV suggested recent infection and HEV did not appear to coinfect with other common hepatotropic viruses. The source of HEV infection in the population remains unclear. These findings are interesting but preliminary. Additional data are required to determine whether HEV infections are responsible for otherwise unexplained acute hepatitis in the Canadian Inuit population and visitors returning from northern North American communities.

Keywords: Acute hepatitis, Canada, Hepatitis E virus, Liver, Liver disease, Viral hepatitis


The hepatitis E virus (HEV) is a nonenveloped, spherical RNA virus that was initially classified as a calicivirus but is now considered a member of the Hepeviridae family of RNA viruses (1). Clinical presentations of HEV infection in humans are similar to most other forms of acute viral hepatitis, with the exception that mortality rates can approach 20% in pregnant women (2,3). Chronic infection with this virus does not occur (4).

The diagnosis of acute HEV infection is largely confined to serological testing and molecular genomic analysis by reverse transcriptase polymerase chain reaction (RT-PCR) (5,6). Thus, to diagnose acute HEV, either immunoglobulin (Ig) M anti-HEV or RT-PCR testing can be used (7,8). For evidence of previous infection, IgG anti-HEV is considered to be highly sensitive and specific (greater than 95%, respectively) (9,10).

HEV is transmitted by the fecal-oral route (1). Typically, this involves ingesting water or food contaminated by infected feces (6). Recent studies (1114) have reported that HEV can be detected in primates, swine and deer, and that humans can become infected by consuming the meat of these animals. Because North American caribou are closely related to deer, it is possible that caribou may also carry the HEV infection. This could represent a potential health risk to the Canadian Inuit because caribou meat is a staple of their diet. The purpose of the present study was to document the prevalence of serological markers for HEV infection in a remote, northern Canadian Inuit community.

PATIENTS AND METHODS

Study population and serological testing

The study community is an inland settlement south of the Arctic Circle and north of the Canadian treeline. The size of the community at the time the samples were collected (1980) was approximately 800 individuals (15).

Most families within the community derive their income from hunting, fishing or federal government assistance. Travel in and out of the community is largely by plane, and is limited to individuals visiting family members in adjacent communities and medical evacuations to the nearest medical centre in Churchill, Manitoba. Most, if not all, community inhabitants have not travelled outside Canada. Tourist activity is limited.

Caribou meat, fish and processed food from southern Canadian centres constitute the staple diet. Caribou meat is usually eaten raw when obtained by hunting ‘on the land’. Caribou meat stored outside of dwellings within the community is either eaten raw, fried, or cooked in warm or hot water for 30 min to 45 min.

Human serum samples from inhabitants of the community, which were collected in 1980 and kept frozen at −80°C, were thawed for testing (15). For each individual, their dwelling within the community was assigned a number and their status within the family unit (eg, father, mother, son, etc) was recorded. Caribou sera (kindly provided by Drs Rick Farnell, Philip Merchant and Dorothy Cooley, Yukon Department of Environment, Whitehorse, Yukon) were derived from the Porcupine and Chisana Woodland herds in regions adjacent to the study community. Serological testing was performed using commercially available kits from Genelabs Diagnostics (USA). ELISA was used to detect IgG and IgM anti-HEV following the manufacturer’s instructions. Samples that were IgG anti-HEV-positive were retested in duplicate. If all three test results were positive, the sample was considered positive and was further tested (in duplicate) for IgM anti-HEV and HEV RNA. HEV RNA testing was performed by RT-PCR. Serum RNA was isolated using a High Pure Viral RNA Kit (Roche Diagnostics, Canada) and RT-PCR was performed as described by Mizuo et al (16). Positive controls were provided by Dr C Osiowy at the National Microbiology Laboratory in Winnipeg, Manitoba. Serological testing for hepatitis A virus (HAV), hepatitis B virus (HBV) and hepatitis C virus (HCV) infections was performed as described previously (15,17).

All individuals or their guardians provided informed consent in 1980 for future testing of newly discovered hepatotropic viruses and/or variants of established causes of viral hepatitis. The study protocol was approved by the University of Manitoba’s Biomedical Research Ethics Board.

Statistics

Categorical variables were evaluated using χ2 analysis. The χ2 test of association (or F test when warranted) was used to examine whether the presence of anti-HEV was associated with positive results of serological testing for HAV, HBV or HCV. Continuous variables were compared using Student’s t test. Statistical significance was achieved when P values fell below 5% in all analyses. Statistical analyses were performed using NCSS and PASS statistical software (NCSS, USA).

RESULTS

The study sample consisted of 393 sera (representing approximately 50% of the community inhabitants), 11 (3%) of whom were IgG anti-HEV-positive (Table 1). Their mean age was 29±8 years and three of the 10 (30%) in whom sex was known were male. Two of the 11 samples (18%) were IgM anti-HEV-positive. Neither of these nor the remaining nine IgG anti-HEV-positive samples were HEV-RNA-positive. All 11 anti-HEV-positive individuals had normal liver enzyme tests (serum aminotransferases, alkaline phosphatase and gamma glutamyl transpeptidase levels) and were rheumatoid factor-negative. Seven (64%) were anti-HAV-positive, five (46%) were HBV seropositive (either HBV surface antigen, or antibody to HBV surface or core antigen-positive) and none (0%) were anti-HCV-positive. There were no associations between the presence of anti-HEV and positive serology for HAV, HBV or HCV. When analyzed with respect to family dwellings, none of the 11 anti-HEV-positive individuals resided in the same dwelling, nor were they first-degree relatives to each other.

TABLE 1.

Anti-hepatitis E virus (anti-HEV) seropositivity in an isolated Canadian Inuit population

Patient Age, years Sex IgG anti-HEV IgM anti-HEV HEV RNA Anti-HAV HBV-seropositive Anti-HCV
1 7 Male +
2 8 Male + +
3 10 Male +
4 15 Female + +
5 16 Female + + +
6 21 Female + +
7 36 Female + +
8 43 Female + + +
9 67 Female + + + +
10 87 Female + + + +
11 9 Unknown +
Anti-HEV+ (n=11) 29±8* 30% male 100% 18% 0% 64% 46% 0%
Anti-HEV– (n=382) 22±1* 51% male 0% NT NT 68% 22% 1%
*

Mean ± SD.Negative; + Positive; HAV Hepatitis A virus; HBV Hepatitis B virus-seropositive (either HBV surface antigen or antibody to HBV core or surface antigen-positive); HCV Hepatitis C virus; IgG/M Immunoglobulin G/M; NT Not tested

The age and sex distributions of the remaining 382 anti-HEV-negative individuals are also provided in Table 1. Their mean age was 22±1 years and 194 (51%) were male. Two hundred seven (68%) had been previously documented to be anti-HAV-positive, 86 (22%) HBV seropositive and four (1.0%) anti-HCV-positive (15,17).

IgG and IgM anti-HEV testing in all 25 caribou sera was negative.

DISCUSSION

To date, essentially all reported cases of HEV in Canada have been described in travellers returning from tropical and/or developing nations (18,19). The prevalence of HEV in a community-based North American population or, indeed, any community-based population throughout the world has yet to be reported. Although the results of the present study are limited to one community of a selected Canadian population, they do suggest that HEV infections unrelated to travel or working with pigs are occurring in North America and specifically within this northern indigenous population.

The 3% prevalence rate described in the present study should only be considered to be an estimate of the true prevalence of HEV in this region. The half-life of IgG anti-HEV is relatively short and may become negative within one year of infection (20,21). Thus, other community inhabitants may have been infected with HEV in the more remote past, but were seronegative at the time blood samples were obtained. False-positive results must also be considered. Although all positive specimens were tested in triplicate and were negative for rheumatoid factor, the presence of a not yet recognized cross-reacting antibody cannot be excluded.

Two of the 11 anti-HEV-positive samples also tested positive for IgM anti-HEV, consistent with recent HEV infections. However, the normal liver enzymes and negative HEV-RNA testing in these samples would be unusual for acute HEV. Whether these specimens are false-positive for IgM anti-HEV or reflect the known decline in serum aminotransferases and viral RNA stability with storage of sera over prolonged periods of time remains to be determined (22,23).

That anti-HEV positivity was not associated with serological evidence of infection with other hepatotropic viruses, and HAV in particular, suggests that in this community, the two viruses may be transmitted by different routes. In the case of HEV, given the reported transmission of HEV from deer to humans, and similarities between deer and caribou, it is proposed that consumption of uncooked or insufficiently cooked caribou meat may be responsible (13,14). In the case of HAV, contaminated drinking water within the community has been implicated most often (24). Similarly, a lack of association with serological evidence of HBV argues against maternal-infant HEV transmission, the most common mode of HBV infection in the community (15). There were too few anti-HCV-positive cases to explore an association with this virus and thereby implicate parenteral routes of HEV infection in this community.

The negative HEV results in caribou sera argue against the possibility that caribou meat is responsible for introducing HEV into the community. However, it should be noted that the caribou tested were from Woodland rather than Barrenland herds, the latter being consumed by this particular Inuit population. Moreover, the prevalence of HEV infection in caribou may be low, rendering 25 serum samples insufficient for the present study. Finally, the serological assays used for caribou testing incorporated goat anti-human Ig which may not have captured caribou Ig. Thus, further testing of caribou and other components of the Inuit diet are warranted.

CONCLUSION

Approximately 3% of this Canadian Inuit population have serological evidence of HEV infection. These results support the need for further studies to determine whether HEV is the cause of unexplained acute hepatitis in individuals residing in or visiting the northern regions of North America.

Acknowledgments

The present study was supported by a grant from the Bloodborne Pathogens Section of the Public Health Agency of Canada (Ottawa, Ontario). The authors would like to thank Ms T Chicheluk for her prompt and accurate typing of the manuscript. Dr A Sun is the recipient of a Canadian Liver Foundation Summer Student Award.

REFERENCES

  • 1.Purcell RH, Emerson SU. Hepatitis E virus. In: Knipe D, Howley P, Griffin D, Lamb R, Martin M, Straus S, editors. Field’s Virology. 4th edn. Philadelphia: Lippincott Williams & Wilkins; [Google Scholar]
  • 2.Fix AD, Abdel-Hamid M, Purcell RH, et al. Prevalence of antibodies to hepatitis E in two rural Egyptian communities. Am J Trop Med Hyg. 2000;62:519–23. doi: 10.4269/ajtmh.2000.62.519. [DOI] [PubMed] [Google Scholar]
  • 3.Kumar A, Beniwal M, Kar P, Sharma JB, Murthy NS. Hepatitis E in pregnancy. Int J Gynaecol Obstet. 2004;85:240–4. doi: 10.1016/j.ijgo.2003.11.018. [DOI] [PubMed] [Google Scholar]
  • 4.Poddar U, Thapa BR, Prasad A, Sharma AK, Singh K. Natural history and risk factors in fulminant hepatic failure. Arch Dis Child. 2002;87:54–6. doi: 10.1136/adc.87.1.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Mansuy JM, Peron JM, Abravanel F, et al. Hepatitis E in the south west of France in individuals who have never visited an endemic area. J Med Virol. 2004;74:419–24. doi: 10.1002/jmv.20206. [DOI] [PubMed] [Google Scholar]
  • 6.Richman DD, Whitley RJ, Hayden FG. Clinical Virology. 2nd edn. Washington, DC: ASM Press; 2002. pp. 1061–71. [Google Scholar]
  • 7.Mitsui T, Tsukamoto Y, Suzuki S, et al. Serological and molecular studies on subclinical hepatitis E virus infection using periodic serum samples obtained from healthy individuals. J Med Virol. 2005;76:526–33. doi: 10.1002/jmv.20393. [DOI] [PubMed] [Google Scholar]
  • 8.Reyes GR, Huang CC, Yarbough PO, Tam AW. Hepatitis E virus. Comparison of ‘New and Old World’ isolates. J Hepatol. 1991;13:S155–61. doi: 10.1016/0168-8278(91)90050-l. [DOI] [PubMed] [Google Scholar]
  • 9.Mast EE, Alter MJ, Holland PV, Purcell RH. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology. 1998;27:857–61. doi: 10.1002/hep.510270331. [DOI] [PubMed] [Google Scholar]
  • 10.Tsarev SA, Tsareva TS, Emerson SU, et al. ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: Identification of HEV infection in primates. J Infect Dis. 1993;168:369–78. doi: 10.1093/infdis/168.2.369. [DOI] [PubMed] [Google Scholar]
  • 11.van der Poel WH, Verschoor F, van der Heide R, et al. Hepatitis E virus sequences in swine related to sequences in human, The Netherlands. Emerg Infect Dis. 2001;7:970–6. doi: 10.3201/eid0706.010608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Takahashi K, Kitajima N, Abe N, Mishiro S. Complete or near-complete nucleotide sequences of hepatitis E virus genome recovered from a wild boar, a deer, and four patients who ate the deer. Virology. 2004;330:501–5. doi: 10.1016/j.virol.2004.10.006. [DOI] [PubMed] [Google Scholar]
  • 13.Tei S, Kitajima N, Ohara S, et al. Consumption of uncooked deer meat as a risk factor for hepatitis E virus infection: An age-and sex-matched case-control study. J Med Virol. 2004;74:67–70. doi: 10.1002/jmv.20147. [DOI] [PubMed] [Google Scholar]
  • 14.Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet. 2003;362:371–3. doi: 10.1016/S0140-6736(03)14025-1. [DOI] [PubMed] [Google Scholar]
  • 15.Minuk GY, Nicolle LE, Postl B, Waggoner JG, Hoofnagle JH. Hepatitis virus infection in an isolated Canadian Inuit (Eskimo) population. J Med Virol. 1982;10:255–64. doi: 10.1002/jmv.1890100405. [DOI] [PubMed] [Google Scholar]
  • 16.Mizuo H, Suzuki K, Takikawa Y, et al. Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan. J Clin Microbiol. 2002;40:3209–18. doi: 10.1128/JCM.40.9.3209-3218.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Minuk GY, Nicolle LE, Gauthier T, Brunka J. The prevalence of antibody to hepatitis C virus in an isolated Canadian Inuit settlement. Can J Infect Dis. 1991;2:71–3. doi: 10.1155/1991/750564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Chaudhary RK, Morbey M, Yarbough PO. Detection of hepatitis E virus antibody in Canada. Can J Infect Dis. 1995;6:264–5. [Google Scholar]
  • 19.Statistics and Risk Assessment Section, Health Care Acquired Infections Division, Centre for Infectious Disease Prevention and Control Blood-borne pathogens routine surveillance system report. Can Commun Dis Rep. 2002;28(Suppl 2):1–59. [PubMed] [Google Scholar]
  • 20.Liao S, Yang Z, Jiang Y, Zhan M. [Dynamic changes of serum antibody titer and liver ultrastructural pathology in acute sporadic hepatitis E virus infected patients] Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 1997;11:244–6. [PubMed] [Google Scholar]
  • 21.Favorov MO, Khudyakov YE, Mast EE, et al. IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein. J Med Virol. 1996;50:50–8. doi: 10.1002/(SICI)1096-9071(199609)50:1<50::AID-JMV10>3.0.CO;2-1. [DOI] [PubMed] [Google Scholar]
  • 22.Cuccherini B, Nussbaum SJ, Seeff LB, Lukacs, Zimmerman HJ. Stability of aspartate aminotransferase and alanine aminotransferase activities. J Lab Clin Med. 1983;102:370–6. [PubMed] [Google Scholar]
  • 23.Vaughan H, Chalker VJ, Mee Z, Rossouw A, James V. Stability of lyophilised specimens for the molecular detection of viral DNA/RNA. J Clin Virol. 2006;35:135–40. doi: 10.1016/j.jcv.2005.06.001. [DOI] [PubMed] [Google Scholar]
  • 24.Minuk GY, Waggoner JG, Jernigan R, Nicolle LE, Postl B, Hoofnagle JH. Prevalence of antibody to hepatitis A virus in a Canadian Inuit community. Can Med Assoc J. 1982;127:850–2. [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Journal of Gastroenterology are provided here courtesy of Wiley

RESOURCES